Advertisement
UK markets closed
  • NIKKEI 225

    38,482.11
    +379.67 (+1.00%)
     
  • HANG SENG

    17,915.55
    -20.57 (-0.11%)
     
  • CRUDE OIL

    81.49
    -0.08 (-0.10%)
     
  • GOLD FUTURES

    2,342.40
    -4.50 (-0.19%)
     
  • DOW

    38,834.86
    +56.76 (+0.15%)
     
  • Bitcoin GBP

    51,326.15
    -1,052.69 (-2.01%)
     
  • CMC Crypto 200

    1,337.38
    -52.02 (-3.74%)
     
  • NASDAQ Composite

    17,862.23
    +5.21 (+0.03%)
     
  • UK FTSE All Share

    4,467.95
    +30.42 (+0.69%)
     

Single Photon Emission Computed Tomography (SPECT) Global Market is Projected to Reach $3.3 Billion by 2030 at a CAGR of 7.1%

Company Logo
Company Logo

Global Market for Single Photon Emission Computed Tomography (SPECT)

Global Market for Single Photon Emission Computed Tomography (SPECT)
Global Market for Single Photon Emission Computed Tomography (SPECT)

Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Single Photon Emission Computed Tomography (SPECT): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2022-2030.

Standalone, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$1.8 Billion by the end of the analysis period.

ADVERTISEMENT

Taking into account the ongoing post pandemic recovery, growth in the Hybrid segment is readjusted to a revised 7.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $690.4 Million, While China is Forecast to Grow at 9.7% CAGR

The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$690.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$399.5 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 6.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Select Competitors (Total 45 Featured) -

  • Beijing Hamamatsu Photon Techniques Inc.

  • Bracco Imaging

  • Bruker Corporation

  • Cadinal Health Inc

  • Curium

  • DDD-Diagnostic A/S

  • Digirad Corporation

  • GE Healthcare (GE Company)

  • Koninklijke Philips N.V.

  • Mediso Ltd.

  • MiE America, Inc.

  • Novartis AG

  • Siemens Healthcare

  • Spectrum Dynamics Medical

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

  • Global competitiveness and key competitor percentage market shares

  • Market presence across multiple geographies - Strong/Active/Niche/Trivial

  • Online interactive peer-to-peer collaborative bespoke updates

  • Access to digital archives and Research Platform

  • Complimentary updates for one year

Key Attributes:

Report Attribute

Details

No. of Pages

469

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$1.9 Billion

Forecasted Market Value (USD) by 2030

$3.3 Billion

Compound Annual Growth Rate

7.1%

Regions Covered

Global

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession

  • SPECT in Diagnosing Pulmonary Embolism amid COVID-19 Pandemic

  • Single Photon Emission Computed Tomography (SPECT) - Global Key Competitors Percentage Market Share in 2022 (E)

  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

  • A Prelude to Single-Photon Emission Computed Tomography (SPECT)

  • Prominent Indications for SPECT Scanning

  • Global SPECT Market to Witness Steady Growth over the Coming Years

  • Hybrid SPECT Systems Witness Increased Demand.

  • Cardiology Dominates the Application for SPECT

  • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others

  • United States Dominates the Global SPECT Market, Asia-Pacific to Register Faster Growth

  • Competition

  • Recent Market Activity

  • WORLD BRANDS

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • SPECT Dominates the Nuclear Medicine Market

  • Global Radiopharmaceuticals Market Revenues in U$ Million for Years 2019, 2021, 2023 & 2025

  • Worldwide Installed Base of Nuclear Imaging Equipment by Modality (2019): Percentage Breakdown of Units Installed for PET and SPECT

  • SPECT Systems with Anger Camera Remain the Dominant Type

  • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth

  • Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050

  • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging

  • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030

  • Oncology Diagnostic Imaging to Witness Rapid Growth

  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040

  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018

  • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging

  • Rise in Healthcare Expenditure to Drive Growth

  • Elderly Healthcare Expenditure as a % of GDP

  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023

  • SPECT Systems with Anger Camera Remain the Dominant Type

  • Growing Demand for Dual-Modality and Organ-Specific Systems Augurs Well

  • Growing Adoption of Hybrid Diagnostic Imaging Modalities

  • SPECT-CT

  • Commercialization of SPECT/CT Systems with Enhanced Features Surges

  • SPECT Combined with CT and PET, the new Rage

  • Integration of X-ray CT Enhances SPECT Capabilities

  • Proper Selection of Isotopes Highly Important for SPECT

  • Sustained Opportunities for Ga-67 SPECT Systems

  • PET Eclipses SPECT in Cardiovascular Imaging

  • Personalized Medicine Drives SPECT Market

  • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population

  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024

  • Rise in Incidence of Neurological Disorders to Drive Growth

  • Technological Advancements in the Recent Past

  • Yale University Research Team Attempts to use Deep Learning for Estimating Attenuation Maps using SPECT Emission Data (2020)

  • Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System

  • NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals

  • Technological Advancements in Cardiac SPECT (2019)

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/s8jl4a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900